ledaborbactam   Click here for help

GtoPdb Ligand ID: 13082

Synonyms: VNRX-5236
Compound class: Synthetic organic
Comment: Ledaborbactam (VNRX-5236) is a novel broad-spectrum boronic acid β-lactamase inhibitor (BLI). It is a reversible covalent inhibitor of serine β-lactamases (classes A, C, D) [1].
Ledaborbactam etzadroxil (VNRX-7145, PubChem CID 138455030), an orally bioavailable prodrug of ledaborbactam [3], is being developed in combination with ceftibuten for the treatment of infections caused by drug-resistant Enterobacterales.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 95.86
Molecular weight 263.05
XLogP 0.49
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(=O)N[C@H]1CC2=CC=CC(=C2OB1O)C(=O)O
Isomeric SMILES B1([C@H](CC2=C(O1)C(=CC=C2)C(=O)O)NC(=O)CC)O
InChI InChI=1S/C12H14BNO5/c1-2-10(15)14-9-6-7-4-3-5-8(12(16)17)11(7)19-13(9)18/h3-5,9,18H,2,6H2,1H3,(H,14,15)(H,16,17)/t9-/m0/s1
InChI Key QAGGLFCWUVSERJ-VIFPVBQESA-N
No information available.
Summary of Clinical Use Click here for help
Ledaborbactam etzadroxil (VNRX-7145) is under clinical development by Venatorx Pharmaceuticals. Phase 1 studies have been completed to evaluate the pharmacokinetics, safety, and tolerability of ledaborbactam etzadroxil + ceftibuten in healthy participants and those with renal impairment (NCT04877379, NCT04243863, NCT05527834, and NCT05488678).